Considering Photodynamic Therapy as a Therapeutic Modality in Selected Cases of Dome-Shaped Macula Complicated by Foveal Serous Retinal Detachment

2015 ◽  
Vol 46 (2) ◽  
pp. 217-223 ◽  
Author(s):  
Ilir Arapi ◽  
Piergiorgio Neri ◽  
Cesare Mariotti ◽  
Rosaria Gesuita ◽  
Vittorio Pirani ◽  
...  
Keyword(s):  
Photodynamic Therapy ◽  
Retinal Detachment ◽  
Serous Retinal Detachment ◽  
Therapeutic Modality

Transient serous retinal detachment after photodynamic therapy for polypoidal choroidal vasculopathy

2008 ◽  
Vol 52 (6) ◽  
pp. 518-520 ◽  
Author(s):  
Hideaki Tobita ◽  
Kyoko Ohno-Matsui ◽  
Manabu Ogawa ◽  
Yuh Kaneko ◽  
Noriaki Shimada ◽  
...  
Keyword(s):  
Photodynamic Therapy ◽  
Retinal Detachment ◽  
Polypoidal Choroidal Vasculopathy ◽  
Serous Retinal Detachment ◽  
Choroidal Vasculopathy

Nanocarriers for Photodynamic Therapy Intended to Cutaneous Tumors

2021 ◽  
Vol 22 ◽  
Author(s):  
Maria Bernadete Riemma Pierre
Keyword(s):  
Photodynamic Therapy ◽  
Drug Delivery Systems ◽  
Active Agent ◽  
Therapeutic Modality ◽  
Tissue Penetration ◽  
Promising Tool ◽  
Skin Cancers ◽  
Superficial Basal Cell Carcinoma ◽  
The Stability ◽  
Disor Ders

Abstract: Photodynamic Therapy (PDT) is a therapeutic modality used for several malignant and premalignant skin disor-ders, including Bowen's disease skin cancers and Superficial Basal Cell Carcinoma (BCC). Several photosensitizers (PSs) have been explored for tumor destruction of skin cancers, after their activation by a light source of appropriate wavelength. Topical release of PSs avoids prolonged photosensitization reactions associated with systemic administration; however, its clinical usefulness is influenced by its poor tissue penetration and the stability of the active agent. Nanotechnology-based drug delivery systems are promising tool to enhance the efficiency for PDT of cancer. This review focuses on PSs encap-sulated in nanocarriers explored for PDT of skin tumors.

Sign in / Sign up

Export Citation Format

Share Document